drugset / Trial / NCT07766655
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is a Phase 3, multicenter, randomized, double-blind, placebo- and active-controlled, parallel-group trial to evaluate the efficacy and safety of AXS-05 compared to placebo and bupropion for smoking cessation in adults.
Timeline
- Start
- 2026-08-27
- Primary completion
- 2027-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AXS-05 | Unknown | — | — |
| Subject | Bupropion | Small molecule | — | — |
Indications
No indication recorded.